More NewsRead More
Alkermes Announces Initiation of Phase 1 Clinical Study of Immuno-Oncology Drug Candidate ALKS 4230
May 25, 2016
Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology Annual Meeting
May 24, 2016
Alkermes Plc (NASDAQ:ALKS) Begins New Study As Acorda Therapeutics, Inc. (NASDAQ:ACOR) Discontinues Theirs
May 27, 2016
from Market Exclusive
Alkermes plc Reports First Quarter 2016 Financial Results
April 28, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here